Brainsway - News Flash - Israel
Brainsway announced it has received the Frost & Sullivan 2012 Global New Product Innovation Award in neuro-psychiatric Devices for its Deep Transcranial Magnetic Stimulation (TMS) system. Frost & Sullivan is a Growth Partnership company that provides its clients researches, models and growth strategies. Brainsway, headquartered in Jerusalem, Israel, is developing noninvasive medical devices for the treatment of neurological and psychopathological disorders, such as addiction, schizophrenia, Alzheimer’s disease and post-traumatic stress disorder. Their initial focus is the treatment of major depression. View and share
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
![](https://nocamels.com/wp-content/uploads/2018/02/INSIGHTEC-350x180.jpg)
Israeli Ultrasound Creator Collaborating On Neuroscience R&D In US
September 05, 2024
![The Weizmann Institute of Science. Photo via the Weizmann Institute of Science](https://nocamels.com/wp-content/uploads/2018/07/weizmann-350x252.jpg)
Weizmann In World’s Top 10 For Biomedical And Overall Research
September 05, 2024
![](https://nocamels.com/wp-content/uploads/2024/09/Depositphotos_75148477_L-350x228.jpg)
Israeli NGO Begins New Mental Health Training In Ukraine
September 04, 2024
![](https://nocamels.com/wp-content/uploads/2024/09/17123254699_79ff768811_ks-350x213.jpg)
Nonprofit Launches Loans For Stricken Northern Israel Businesses
September 04, 2024
Facebook comments